Correlation Between Veracyte and Denali Therapeutics
Can any of the company-specific risk be diversified away by investing in both Veracyte and Denali Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Denali Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Denali Therapeutics, you can compare the effects of market volatilities on Veracyte and Denali Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Denali Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Denali Therapeutics.
Diversification Opportunities for Veracyte and Denali Therapeutics
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Veracyte and Denali is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Denali Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Denali Therapeutics and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Denali Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denali Therapeutics has no effect on the direction of Veracyte i.e., Veracyte and Denali Therapeutics go up and down completely randomly.
Pair Corralation between Veracyte and Denali Therapeutics
Given the investment horizon of 90 days Veracyte is expected to generate 1.11 times more return on investment than Denali Therapeutics. However, Veracyte is 1.11 times more volatile than Denali Therapeutics. It trades about -0.29 of its potential returns per unit of risk. Denali Therapeutics is currently generating about -0.41 per unit of risk. If you would invest 4,506 in Veracyte on December 3, 2024 and sell it today you would lose (1,150) from holding Veracyte or give up 25.52% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Veracyte vs. Denali Therapeutics
Performance |
Timeline |
Veracyte |
Denali Therapeutics |
Veracyte and Denali Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Veracyte and Denali Therapeutics
The main advantage of trading using opposite Veracyte and Denali Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Denali Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will offset losses from the drop in Denali Therapeutics' long position.Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular Therapeutics | Denali Therapeutics vs. Ascendis Pharma AS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |